Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Xu H, Robinson GW, Huang J, Lim JY, Zhang H, Bass JK, Broniscer A, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Fisher M, Cohn R, Yamashita T, Teitz T, Zuo J, Onar-Thomas A, Gajjar A, Stewart CF, Yang JJ. Xu H, et al. Among authors: fisher m. Nat Genet. 2015 Mar;47(3):263-6. doi: 10.1038/ng.3217. Epub 2015 Feb 9. Nat Genet. 2015. PMID: 25665007 Free PMC article.
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Xu H, Robinson GW, Huang J, Lim JY, Zhang H, Bass JK, Broniscer A, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Fisher M, Cohn R, Yamashita T, Teitz T, Zuo J, Onar-Thomas A, Gajjar A, Stewart CF, Yang JJ. Xu H, et al. Among authors: fisher m. Nat Genet. 2015 Apr;47(4):423. doi: 10.1038/ng0415-423. Nat Genet. 2015. PMID: 25814313 No abstract available.
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.
Packer RJ, Rood BR, Turner DC, Stewart CF, Fisher M, Smith C, Young-Pouissant T, Goldman S, Lulla R, Banerjee A, Pollack I, Kun L, Onar-Thomas A, Wu S, Boyett JM, Fouladi M. Packer RJ, et al. Among authors: fisher m. J Neurooncol. 2015 Jan;121(1):217-24. doi: 10.1007/s11060-014-1665-1. Epub 2014 Nov 19. J Neurooncol. 2015. PMID: 25407389 Free PMC article. Clinical Trial.
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.
Xiong Y, Campbell BCV, Schwamm LH, Meng X, Jin A, Parsons MW, Fisher M, Jiang Y, Che F, Wang L, Zhou L, Dai H, Liu X, Pan Y, Duan C, Xu Y, Xu A, Zong L, Tan Z, Ye W, Wang H, Wang Z, Hao M, Cao Z, Wang L, Wu S, Li H, Li Z, Zhao X, Wang Y; TRACE-III Investigators. Xiong Y, et al. Among authors: fisher m. N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMoa2402980. Online ahead of print. N Engl J Med. 2024. PMID: 38884324
Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study.
Borghese MM, Ward A, MacPherson S, Manz KE, Atlas E, Fisher M, Arbuckle TE, Braun JM, Bouchard MF, Ashley-Martin J. Borghese MM, et al. Among authors: fisher m. Environ Health. 2024 Jun 10;23(1):55. doi: 10.1186/s12940-024-01085-z. Environ Health. 2024. PMID: 38858670 Free PMC article.
Exploring the Limits of Endovascular Therapy for Large Core Patients: Where Do We Need More Data?
Albers GW, Heit JJ, Lansberg MG, Inoue M, Huo X, Yedavalli VS, Seners P, McCullough-Hicks M, Cereda CW, Tsai JP, Mistry EA, Chatterjee AR, Derdeyn CP, Khatri P, Olivot JM, Hill MD, Saver JL, Fisher M. Albers GW, et al. Among authors: fisher m. Stroke. 2024 Jun 5. doi: 10.1161/STROKEAHA.124.047228. Online ahead of print. Stroke. 2024. PMID: 38836345 No abstract available.
5,481 results